A trusted partner in bringing new medicines to life. Fast. Sai Life Sciences is a fast-growing global Contract Research, Development & Manufacturing Organization (CRO-CDMO) that works with innovator biotech and pharma companies to accelerate the discovery, development and commercialization of complex small molecules. We take a nimble and creative approach to deliver high-quality, cost-effective solutions to accelerate the time to market. Over the past 22+ years, we have served a diverse set of NCE development programs, consistently delivering value based on our scientific strength and client focus. Today, Sai Life Sciences works with over 200 innovator pharma and biotech companies across the world, spanning start-ups, small & mid-sized pharma, and large pharma companies. As one of the fastest growing CRO-CDMOs in the region, we have invested US$110 Mn in augmenting our R&D and manufacturing capabilities, including setting up a Biology Lab in Boston (USA) and a Process R&D Lab in Manchester, UK. Sai Life Sciences is the first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI). Backed by TPG Capital and HBM Healthcare Investments, the company today has over 2200 employees across its facilities in India, UK and USA.